^
Association details:
| Biomarker: | BRAF V600E |
|---|---|
| Cancer: | Colon Cancer |
| Drug: | Vectibix (panitumumab) (EGFR inhibitor) + Braftovi (encorafenib) (BRAF inhibitor, cRAF inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Colon Cancer...SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE - CHEMOTHERAPY REGIMENS...Encorafenib + panitumumab (BRAF V600E mutation positive)
